Analysts' recommendations: Carmat SA

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
10/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

05/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 20/03/2026			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Market Cap	6.15M 7.17M 5.76M 5.26M 9.93M 684M 10.03M 67.93M 26.44M 345M 26.93M 26.34M 1.14B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 69.14M 55.51M 50.71M 95.7M 6.59B 96.64M 655M 255M 3.33B 260M 254M 11.01B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
07/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
07/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
05/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
16/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
05/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Current year	0.1	0.1
1 year	0.08	0.2
3 years	0.08	9.99
5 years	0.08	31.7
10 years	0.08	44.95

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news : Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Course Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/3/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
13/3/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
29/5/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-47.89%	-98.58%	7.08M
STRYKER CORPORATION	+1.09%	-0.17%	-15.37%	+18.94%	126B
SMITH & NEPHEW PLC	-1.29%	-3.83%	-22.61%	+0.85%	12.42B
GLAUKOS CORPORATION	-2.61%	-2.18%	+96.77%	+143.83%	10.95B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.13%	-6.17%	-51.53%	-69.15%	4.1B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.57%	+4.14%	-21.64%	+54.89%	2.77B
INSPIRE MEDICAL SYSTEMS, INC.	-0.50%	+6.69%	-34.12%	-71.60%	1.78B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.12%	-1.53%	-24.53%	-13.60%	1.62B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.47%	-4.57%	-37.22%	-38.64%	1.56B
Average	+0.15%	+0.94%	-17.57%	-8.12%	17.88B
Weighted average by Cap.	+0.73%	-0.83%	-9.84%	+22.52%

	2023	2024
Net sales	3.84M 4.48M 3.6M 3.28M 6.2M 427M 6.26M 42.41M 16.51M 215M 16.81M 16.45M 713M	7.34M 8.57M 6.88M 6.29M 11.86M 817M 11.98M 81.17M 31.6M 412M 32.18M 31.48M 1.37B
Net income	-53.87M -62.86M -50.48M -46.11M -87.01M -5.99B -87.87M -595M -232M -3.02B -236M -231M -10.01B	-51.4M -59.98M -48.16M -43.99M -83.02M -5.72B -83.84M -568M -221M -2.88B -225M -220M -9.55B
Net Debt	49.64M 57.93M 46.51M 42.48M 80.18M 5.52B 80.97M 549M 214M 2.79B 217M 213M 9.23B	53.1M 61.97M 49.76M 45.45M 85.77M 5.91B 86.62M 587M 228M 2.98B 233M 228M 9.87B